PET-CT in Clinical Adult Oncology—V. Head and Neck and Neuro Oncology
PET-CT is an advanced imaging modality with many oncologic applications, including staging, assessment of response to therapy, restaging, and longitudinal surveillance for recurrence. The goal of this series of six review articles is to provide practical information to providers and imaging professi...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-05-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/14/11/2726 |
| _version_ | 1797493894477250560 |
|---|---|
| author | Richard H. Wiggins John M. Hoffman Gabriel C. Fine Matthew F. Covington Ahmed Ebada Salem Bhasker R. Koppula Kathryn A. Morton |
| author_facet | Richard H. Wiggins John M. Hoffman Gabriel C. Fine Matthew F. Covington Ahmed Ebada Salem Bhasker R. Koppula Kathryn A. Morton |
| author_sort | Richard H. Wiggins |
| collection | DOAJ |
| description | PET-CT is an advanced imaging modality with many oncologic applications, including staging, assessment of response to therapy, restaging, and longitudinal surveillance for recurrence. The goal of this series of six review articles is to provide practical information to providers and imaging professionals regarding the best use of PET-CT for specific oncologic indications, and the potential pitfalls and nuances that characterize these applications. In addition, key tumor-specific clinical information and representative PET-CT images are provided to outline the role that PET-CT plays in the management of oncology patients. Hundreds of different types of tumors exist, both pediatric and adult. A discussion of the role of FDG PET for all of these is beyond the scope of this review. Rather, this series of articles focuses on the most common adult malignancies that may be encountered in clinical practice. It also focuses on FDA-approved and clinically available radiopharmaceuticals, rather than research tracers or those requiring a local cyclotron. The fifth review article in this series focuses on PET-CT imaging in head and neck tumors, as well as brain tumors. Common normal variants, key anatomic features, and benign mimics of these tumors are reviewed. The goal of this review article is to provide the imaging professional with guidance in the interpretation of PET-CT for the more common head and neck malignancies and neuro oncology, and to inform the referring providers so that they can have realistic expectations of the value and limitations of PET-CT for the specific type of tumor being addressed. |
| first_indexed | 2024-03-10T01:26:32Z |
| format | Article |
| id | doaj.art-22b0b18929024fb4aee02b15e96acc10 |
| institution | Directory Open Access Journal |
| issn | 2072-6694 |
| language | English |
| last_indexed | 2024-03-10T01:26:32Z |
| publishDate | 2022-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cancers |
| spelling | doaj.art-22b0b18929024fb4aee02b15e96acc102023-11-23T13:50:10ZengMDPI AGCancers2072-66942022-05-011411272610.3390/cancers14112726PET-CT in Clinical Adult Oncology—V. Head and Neck and Neuro OncologyRichard H. Wiggins0John M. Hoffman1Gabriel C. Fine2Matthew F. Covington3Ahmed Ebada Salem4Bhasker R. Koppula5Kathryn A. Morton6Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USADepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USADepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USADepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USADepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USADepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USADepartment of Radiology and Imaging Sciences, University of Utah, Salt Lake City, UT 84132, USAPET-CT is an advanced imaging modality with many oncologic applications, including staging, assessment of response to therapy, restaging, and longitudinal surveillance for recurrence. The goal of this series of six review articles is to provide practical information to providers and imaging professionals regarding the best use of PET-CT for specific oncologic indications, and the potential pitfalls and nuances that characterize these applications. In addition, key tumor-specific clinical information and representative PET-CT images are provided to outline the role that PET-CT plays in the management of oncology patients. Hundreds of different types of tumors exist, both pediatric and adult. A discussion of the role of FDG PET for all of these is beyond the scope of this review. Rather, this series of articles focuses on the most common adult malignancies that may be encountered in clinical practice. It also focuses on FDA-approved and clinically available radiopharmaceuticals, rather than research tracers or those requiring a local cyclotron. The fifth review article in this series focuses on PET-CT imaging in head and neck tumors, as well as brain tumors. Common normal variants, key anatomic features, and benign mimics of these tumors are reviewed. The goal of this review article is to provide the imaging professional with guidance in the interpretation of PET-CT for the more common head and neck malignancies and neuro oncology, and to inform the referring providers so that they can have realistic expectations of the value and limitations of PET-CT for the specific type of tumor being addressed.https://www.mdpi.com/2072-6694/14/11/2726PETFDGhead and neck cancerbrain tumorssquamous cell carcinomacervical esophageal cancer |
| spellingShingle | Richard H. Wiggins John M. Hoffman Gabriel C. Fine Matthew F. Covington Ahmed Ebada Salem Bhasker R. Koppula Kathryn A. Morton PET-CT in Clinical Adult Oncology—V. Head and Neck and Neuro Oncology Cancers PET FDG head and neck cancer brain tumors squamous cell carcinoma cervical esophageal cancer |
| title | PET-CT in Clinical Adult Oncology—V. Head and Neck and Neuro Oncology |
| title_full | PET-CT in Clinical Adult Oncology—V. Head and Neck and Neuro Oncology |
| title_fullStr | PET-CT in Clinical Adult Oncology—V. Head and Neck and Neuro Oncology |
| title_full_unstemmed | PET-CT in Clinical Adult Oncology—V. Head and Neck and Neuro Oncology |
| title_short | PET-CT in Clinical Adult Oncology—V. Head and Neck and Neuro Oncology |
| title_sort | pet ct in clinical adult oncology v head and neck and neuro oncology |
| topic | PET FDG head and neck cancer brain tumors squamous cell carcinoma cervical esophageal cancer |
| url | https://www.mdpi.com/2072-6694/14/11/2726 |
| work_keys_str_mv | AT richardhwiggins petctinclinicaladultoncologyvheadandneckandneurooncology AT johnmhoffman petctinclinicaladultoncologyvheadandneckandneurooncology AT gabrielcfine petctinclinicaladultoncologyvheadandneckandneurooncology AT matthewfcovington petctinclinicaladultoncologyvheadandneckandneurooncology AT ahmedebadasalem petctinclinicaladultoncologyvheadandneckandneurooncology AT bhaskerrkoppula petctinclinicaladultoncologyvheadandneckandneurooncology AT kathrynamorton petctinclinicaladultoncologyvheadandneckandneurooncology |